Adaptimmune Therapeutics PLC - FORM 10-K - EX-21.1 - February 25, 2021

Attached files

file filename
EX-32.1 - EX-32.1 - Adaptimmune Therapeutics PLCadap-20201231xex32d1.htm
EX-4.4 - EX-4.4 - Adaptimmune Therapeutics PLCadap-20201231xex4d4.htm
EX-32.2 - EX-32.2 - Adaptimmune Therapeutics PLCadap-20201231xex32d2.htm
EX-31.2 - EX-31.2 - Adaptimmune Therapeutics PLCadap-20201231xex31d2.htm
EX-31.1 - EX-31.1 - Adaptimmune Therapeutics PLCadap-20201231xex31d1.htm
EX-23.1 - EX-23.1 - Adaptimmune Therapeutics PLCadap-20201231xex23d1.htm
10-K - 10-K - Adaptimmune Therapeutics PLCadap-20201231x10k.htm

Exhibit 21.1

​

Subsidiary Name

Jurisdiction of Formation

​

​

Adaptimmune Limited

England and Wales

​

​

Adaptimmune LLC

Delaware

​

​

Adaptimmune B.V.

The Netherlands

​

Adaptimmune Therapeutics PLC Reports